[The treatment of tuberculosis. I. Mycobacterial subpopulations in the lesions and antitubercular drugs].
作者信息
Corlan E
机构信息
Catedra de Pneumoftiziologie, UMF, Bucureşti.
出版信息
Pneumoftiziologia. 1992 Oct-Dec;41(4):231-42.
PMID:1339503
Abstract
摘要
相似文献
1
[The treatment of tuberculosis. I. Mycobacterial subpopulations in the lesions and antitubercular drugs].[结核病的治疗。I. 病变中的分枝杆菌亚群与抗结核药物]
Pneumoftiziologia. 1992 Oct-Dec;41(4):231-42.
2
Bacteriologic basis of short-course chemotherapy for tuberculosis.结核病短程化疗的细菌学基础
Clin Chest Med. 1980 May;1(2):231-41.
3
[Prognostic value of isolation of drug-resistant Mycobacterium tuberculosis].[耐多药结核分枝杆菌分离的预后价值]
Vrach Delo. 1978 Dec(12):27-30.
4
[Determination of adequate drug combinations in the treatment of cavernous tuberculosis].
Prax Pneumol. 1971 Apr;25(4):211-9.
5
[Respiratory fluoroquinolones and pulmonary tuberculosis treatment when the main drugs are ineffective].[当主要药物无效时，呼吸道氟喹诺酮类药物与肺结核治疗]
Antibiot Khimioter. 2008;53(5-6):14-20.
6
[Significance of determination of drug resistance in Mycobacterium tuberculosis for successful treatment of pulmonary tuberculosis].[结核分枝杆菌耐药性测定对成功治疗肺结核的意义]
Probl Tuberk Bolezn Legk. 2004(4):29-31.
7
[Determination of Mycobacterium tuberculosis' sensitivity to pyrazinamide on a BACTEC-960 bacteriological analyzer].[在BACTEC - 960细菌分析仪上测定结核分枝杆菌对吡嗪酰胺的敏感性]
Probl Tuberk Bolezn Legk. 2003(7):40-2.
8
Evaluation of new antituberculosis drugs in mouse models.小鼠模型中新型抗结核药物的评估。
Antimicrob Agents Chemother. 2007 Jan;51(1):403; author reply 403-4. doi: 10.1128/AAC.01246-06.
9
[Reasons for drug-resistant tuberculosis emergence].[耐多药结核病出现的原因]
Zhonghua Jie He He Hu Xi Za Zhi. 2007 Jun;30(6):403-5.
Zotero 插件